Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital
| Autor: | A.J.H.A. Ament, E. Smeets, E. Broex, E. Nulens, F. H. Van Tiel, Ellen E. Stobberingh, B. Gordts, Ruud H. Deurenberg, J Scheres |
|---|---|
| Přispěvatelé: | Beleid Economie en Organisatie v/d Zorg, Medische Microbiologie, Genetica & Celbiologie, RS: NUTRIM - R3 - Chronic inflammatory disease and wasting, RS: CAPHRI School for Public Health and Primary Care |
| Jazyk: | angličtina |
| Rok vydání: | 2008 |
| Předmět: |
Microbiology (medical)
medicine.medical_specialty Staphylococcus aureus Meticillin medicine.drug_class Cost-Benefit Analysis Antibiotics Bacteremia Staphylococcal infections medicine.disease_cause Floxacillin Hospitals University Diagnostic Tests Vancomycin Internal medicine medicine Infection control Humans Routine Intensive care medicine Antibacterial agent Netherlands University Cross Infection Infection Control business.industry Diagnostic Tests Routine Health Policy General Medicine Health Care Costs Staphylococcal Infections medicine.disease Hospitals Anti-Bacterial Agents Infectious Diseases Methicillin Resistance business medicine.drug |
| Zdroj: | Journal of Hospital Infection, 68(4), 301-307. W.B. Saunders Ltd Journal of Hospital Infection, 68(4), 301-307. W B SAUNDERS CO LTD |
| ISSN: | 0195-6701 |
| Popis: | Costs related to a search and destroy policy and treatment for Staphylococcus aureus bacteraemia in the University Hospital Maastricht were calculated for the period 2000 and 2004. The financial cost-benefit break-even point of the search and destroy policy was determined by modelling. On average 22,412 patients were admitted per year for an average of 8.7 days. Each year 246 patients were screened for meticillin-resistant Staphylococcus aureus (MRSA) and 74 patients were decolonised and nursed in preventive isolation. The prevalence of MRSA in the University Hospital Maastricht was 0.7%, as calculated from positive blood cultures, and mean length of stay for all patients with S. aureus bloodstream infections was 39.9 days. The annual cost of pro-active searching for MRSA in the University Hospital Maastricht was euro 1,383,200, and euro 2,736,762 for MRSA prevention and treatment of S. aureus bloodstream infections. Simulation of a variety MRSA/meticillin-susceptible S. aureus (MSSA) ratios showed that even if the MRSA prevalence reaches 8%, prevention costs are still lower than the cost of treating S. aureus infections. In conclusion, the total cost of a search and destroy policy is lower than the cost of treating S. aureus bloodstream infections in the University Hospital Maastricht. At an MRSA prevalence of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect